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Abstract
Introduction:  In  patients  with  an  indwelling  urinary  catheter  presenting  with  candiduria  and
risk factors  that  favor  its  spread,  the  sudden  onset  of  ocular  symptoms  with  a  decrease  in  visual
acuity should  lead  us  to  suspect  this  organism  as  a  causal  agent.
Clinical  case:  A  56-year-old  Caucasian  man  with  risk  factors  for  Candida  colonization  and  spread
began to  have  ﬂoaters,  photopsia,  and  decreased  visual  acuity  ten  days  after  the  insertion  of  a
double-J stent.
Conclusions:  Antifungal  therapy  should  be  considered  in  patients  that  have  undergone  a  urologic
procedure  and  that  present  with  candiduria  and  associated  risk  factors,  in  order  to  prevent  the
spread of  infections  and  their  subsequent  complications.
© 2016  Sociedad  Mexicana  de  Urolog´ıa.  Published  by  Masson  Doyma  Me´xico  S.A.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Resumen
Antecedentes:  En  pacientes  portadores  de  un  cateter  urinario,  la  presencia  de  Candiduria  y
factores de  riesgo  asociados  favorecen  la  propagación  de  este  germen.  La  aparición  repentinaCateterización en estos  pacientes,  de  síntomas  oculares  con  una  disminución  de  la  agudeza  visual  conduce  a
pensar hacia  la  afectación  ocular  por  dicho  germen.ureteral
Caso  clínico:  Presentamos  el  caso  de  un  paciente  de  56  an˜os  de  edad,  de  raza  caucásica  con
factores de  riesgo  para  la  colonización  por  Candida  y  la  posterior  propagación  de  este  microor-
ganismo,  que  comenzó  a  tener  miodesopsias,  fotopsia  y  disminución  de  la  agudeza  visual  diez
días después  de  la  inserción  de  un  catéter  doble  J.∗ Corresponding author at: I. Abáigar-Pedraza. Servicio de Urología, Bloque B, 7a Planta, Hospital General Universitario de Alicante, Avda.
Pintor Baeza, 12 03010 Alicante, Spain. Tel.: +34 690763765; fax: +34 965913753.
E-mail address: iramedi@hotmail.com (I. Abáigar-Pedraza).
http://dx.doi.org/10.1016/j.uromx.2016.09.003
2007-4085/© 2016 Sociedad Mexicana de Urolog´ıa. Published by Masson Doyma Me´xico S.A. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusiones:  La  necesidad  de  iniciar  el  tratamiento  antifúngico  debe  ser  considerado  en
pacientes  con  candiduria  y  factores  de  riesgo  asociados,  y  que  se  someten  a  un  procedimiento
urológico, con  el  ﬁn  de  evitar  la  propagación  de  infecciones  y  las  complicaciones  provocadas
por estos.
©  2016  Sociedad  Mexicana  de  Urolog´ıa.  Publicado  por  Masson  Doyma  Me´xico  S.A.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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introduction
andida  colonization  does  not  pose  a  threat  to  health  in  a
ealthy  host.  The  systemic  repercussions  resulting  from  Can-
ida  occur  in  patients  with  baseline  comorbidities  or  in  those
ndergoing  certain  procedures,  such  as  ureteral  catheter-
zation,  since  they  increase  the  persistence  of  the  microbe.
e  report  herein  the  case  of  a  patient  that  presented  with
ilateral  Candida  endophthalmitis  after  the  insertion  of  a
ouble-J  ureteral  stent  for  obstructive  uropathy.
ase report
 56-year-old  man  presented  with  overweight,  dyslipidemia,
oorly  controlled  type  2  diabetes  mellitus,  and  lack  of  treat-
ent  adherence.  He  received  ceﬁxime  during  the  previous
eek  for  a  urine  infection.  The  patient  came  to  our  unit  with
omplicated  renal  colic,  which  required  the  insertion  of  a
eft-side  ureteral  catheter.  The  urine  culture  was  positive
or  Streptococcus  peroris.  Intravenous  linezolid  treatment
as  started,  but  fever  persisted  after  5  days.  New  urine
nd  blood  cultures  were  positive  for  Candida  albicans  and
o  ﬂuconazole  was  added  to  the  treatment.  Ten  days  later,
he  fever  persisted  and  the  patient  presented  with  photo-
hobia,  photopsia,  and  blurred  vision.  Because  the  blood
ultures  remained  positive  for  Candida  albicans,  linezolid
herapy  was  suspended  and  treatment  with  ﬂuconazole  was
ontinued.  The  patient  was  evaluated  by  the  ophthalmology
ervice  and  a  funduscopic  examination  revealed  multiple
ilateral,  whitish,  intra-retinal  and  well-circumscribed  inﬁl-
rations  consistent  with  Candida  chorioretinitis.  Systemic
ntibiotic  treatment  was  continued.
Three  weeks  later,  the  blood  culture  was  still  positive  and
he  eye  disorders  did  not  improve.
Treatment  with  voriconazole  was  prescribed  and  even
hough  the  fever  disappeared,  the  eye  alterations  worsened.
ntravitreal  voriconazole  therapy  was  introduced,  but  the
ituation  progressed  with  no  eye  infection  improvement.
ilateral  endophthalmitis  was  diagnosed.  Pars  plana  vitrec-
omy  was  then  performed  and  the  infectious  process  was
ompletely  resolved.
iscussionatients  colonized  with  Candida  and  that  present  with
mmunosuppressive  states,  improperly  controlled  diabetes
ellitus,  long-term  antibiotic  treatment,  or  urine  catheters,
t
i
m
savor  the  survival  and  persistence  of  the  fungus,  with  its
ubsequent  hematogenous  dissemination.1--3 Candida  forms
 bioﬁlm  over  medical  devices  (such  as  urinary  catheters),
hich  leads  to  the  adhesion  of  the  microorganism  and  the
ormation  of  extracellular  polymers  that  provide  a  structural
atrix,  thus  increasing  the  power  of  adhesion  and  persis-
ence  of  the  microorganism.4--6 Tumbarello  et  al.  describe
wo  risk  factors  for  bioﬁlm  formation:  diabetes  mellitus  and
rinary  catheterization.5 Our  patient  had  both.
Microbes  in  bioﬁlms  have  a  more  virulent  behavior
ecause  they  change  the  composition  of  their  own  cells  and
re  refractory  to  medical  treatment  due  to  the  difﬁculty  in
enetrating  the  structural  matrix.  Therefore,  bioﬁlms  are
ssociated  with  increased  morbidity  and  mortality.7,8
When  a  patient  with  candiduria  presents  with  associated
isk  factors,  candidemia  is  triggered.8 The  microbe  is  more
irulent  because  the  bioﬁlm  infects  the  adjacent  tissue  and
ence  the  passage  into  the  bloodstream  is  immediate.  The
ackground  risks  that  trigger  fungemia  are:  antimicrobial  or
orticosteroid  therapy  at  least  one  week  before  the  start  of
ungemia  and  manipulation  of  the  urinary  tract.8 Our  patient
ad  several  of  these  factors  (he  had  double-J  stent  insertion
nd  a  week  before  this  event  he  was  treated  with  ceﬁxime
or  7  days).
After  entering  the  bloodstream,  the  microorganism  can
each  the  eye  and  cause  endogenous  fungal  endophthalmi-
is.  Fungal  endophthalmitis  occurs  in  2--10%  of  all  cases  of
ndophthalmitis.  It  is  bilateral  in  65%  of  the  cases  and
ppears  in  patients  with  immunosuppressive  risk  factors.
he  most  common  primary  origins  are  gastrointestinal
bscesses,  urinary  tract  infections,  and  endocarditis.4,5
The  development  of  symptoms  in  our  patient  coincides
ith  that  described  in  the  literature:  sudden  reduction  of
isual  acuity,  myodesopsia,  and  pain  in  the  eyes.  Initially,
he  retinal  lesions  are  focal,  deep,  white,  and  have  a  cotton-
ike  appearance.  This  begins  with  chorioretinitis,  which  is
ontiguous  and  extends  to  the  vitreous,  leading  to  vitritis,
nd  consequently  to  endophthalmitis.
The  diagnosis  is  clinical:  patient  history,  symptoms,  and
he  lesions  revealed  in  the  funduscopic  study.  It  is  conﬁrmed
hrough  vitreous  culture,  but  involves  many  false  positive
esults  and  a  high  level  of  complications.  The  majority  of
uthors  opt  to  conduct  a  pars  plana  vitrectomy,  which  is
oth  diagnostic  and  therapeutic.  Fungal  endophthalmitis
s  an  uncommon  condition,  but  it  is  one  of  the  main  infec-
ious  causes  of  loss  of  visual  acuity.  The  visual  prognosis
s  very  poor,  and  is  associated  with  the  virulence  of  the
icrobe,  bilateral  involvement,  and  the  delay  in  diagno-
is  and  treatment.6 The  case  presented  herein  is  a  severe
tema
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bilateral  case  with  a  very  virulent  microorganism  that  did
not  respond  to  systemic  or  intravitreal  treatment.
Initial  treatment  consists  of  systemic  therapy  with
amphotericin  B  or  ﬂuconazole  for  a  period  of  three
weeks.  The  second  step  requires  intra-vitreous  adminis-
tration  of  amphotericin  B  5--10  g/0.1  ml  or  voriconazole
100  g/0.1  ml,  and  in  persistent  cases,  a  vitrectomy  must
be  performed.5 Our  patient  required  a  bilateral  vitrectomy,
which  resolved  the  infection.  He  presently  has  a  visual  acuity
of  0.3  in  the  right  eye  and  0.4  in  the  left  eye.
Conclusion
Given  the  serious  outcome  of  our  patient,  we  consider  it
necessary  to  begin  antifungal  therapy  in  all  patients  with
candiduria  and  associated  risk  factors.  The  urologic  proce-
dures  that  may  predispose  to  fungemia  are:  open  surgery,
cystoscopy,  stent  placement,  and  intermittent  urinary  cath-
eterization.  This  was  also  proposed  by  Toshikuni  et  al.,9 who
suggested  the  administration  of  antifungal  agents  before
shockwave  lithotripsy  (SWL)  to  prevent  fungemia  in  patients
with  funguria,  and  by  Vaidyanathan  et  al.,10 in  regard
to  the  administration  of  antifungal  treatment  in  patients
with  spinal  cord  injury  and  candiduria.  Particular  attention
should  be  paid  to  the  appearance  of  ocular  symptoms,  and
particularly  to  a  possible  fungal  endophthalmitis,  with  its
devastating  prognosis.  According  to  the  medical  literature,
up  to  50%  of  hospital  antibiotic  use  is  inappropriate.7 It  is
very  important  to  adjust  treatments  according  to  antibi-
ograms.  In  our  case,  linezolid  was  chosen  to  treat  the
Streptococcus  peroris  for  10  days  and  was  not  changed  after
the  results  of  the  antibiogram.  One  week  later,  our  patient
received  ceﬁxime  for  7  days.  All  of  this  favored  the  spread
of  the  microorganisms  and  helped  develop  the  eye  problem.
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